+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

From
Prostate Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Prostate Cancer Therapeutics - Global Strategic Business Report

  • Report
  • December 2024
  • 212 Pages
  • Global
From
Prostate Cancer Therapeutics Market - Product Thumbnail Image

Prostate Cancer Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
Capecitabine Global Market Report 2024 - Product Thumbnail Image

Capecitabine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Leuprolide Acetate - Global Strategic Business Report - Product Thumbnail Image

Leuprolide Acetate - Global Strategic Business Report

  • Report
  • December 2024
  • 282 Pages
  • Global
From
From
From
Prostate Cancer Devices - Global Strategic Business Report - Product Thumbnail Image

Prostate Cancer Devices - Global Strategic Business Report

  • Report
  • December 2024
  • 276 Pages
  • Global
From
From
From
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more